# Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage

> **NCT02391636** · PHASE4 · COMPLETED · sponsor: **Ghamra Military Hospital** · enrollment: 264 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT02391636
- **Lead sponsor:** Ghamra Military Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-09
- **Final completion:** 2016-12
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2017-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02391636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02391636, "Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02391636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*